As the world continues to take unprecedented action in response to the Coronavirus pandemic, nobody is left unaffected. At Napp, we have responded at pace to ensure that we protect the health of our employees, partners, suppliers, and contractors, as a priority.
Since the outbreak of the virus, Napp has taken all precautions and steps to ensure our supply chain remains robust and that provision of our medicines to the patients that depend on them continues uninterrupted.
We have also worked tirelessly to ensure business continuity plans are in place, so that we can continue to deliver on our commitments to healthcare professionals, patient and professional groups, and external partners. This includes the rapid adoption of novel digital solutions across every part of our business, so that we can continue to deliver a compliant high-quality service that meets the needs of healthcare professionals and our customers.
In response to the challenges facing primary care, we are facilitating a series of non-promotional educational webinars, bringing together leading experts who have so far provided advice to over 1000 UK healthcare professionals on leadership in oncology nursing, as well as type 2 diabetes and respiratory management during Covid-19.
Our employees continue to be fully supported to work flexibly and are home-based wherever possible. For our people with essential roles that require them to be on-site, such as supply and manufacturing, we are actively following all relevant WHO and National guidelines to safeguard them.
At Napp, we all share a deep sense of pride and compassion for those who make up our community, therefore, we are enabling our employees who are medically trained or otherwise and wish to volunteer with the NHS or local causes, to do so during this period.
We know that the impact of this pandemic will be long-term and far-reaching. As such, we remain unwavering in our support – both internally and externally – during these most difficult of times.